检索结果 - Yajin Chen

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Laparoscopic Common Bile Duct Exploration with Primary Closure for Management of Choledocholithiasis: A Retrospective Analysis and Comparison with Conventional T-tube Drainage

    Laparoscopic Common Bile Duct Exploration with Primary Closure for Management of Choledocholithiasis: A Retrospective Analysis and Comparison with Conventional T-tube Drainage 由 Hongwei Zhang, Yajin Chen, Changhao Wu, Wenda Li

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021

    Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021 由 Jiahao Jiang, Zhiqin Xie, Qingbin Wang, Bingkun Wang, Rong Huang, Weikai Xu, Changzhen Shang, Yajin Chen

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States

    Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States 由 Zhiqin Xie, Hongxia Li, Wenliang Tan, Lei Yang, Xiaowu Ma, Wenxin Li, Qingbin Wang, Changzhen Shang, Yajin Chen

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma

    GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma 由 Wenliang Tan, Kelin Zhang, Xinming Chen, Lei Yang, Sicong Zhu, Yingcheng Wei, Zhiqin Xie, Yajin Chen, Changzhen Shang

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET

    Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET 由 Qingfeng Xiang, Weiqiang Chen, Meng Ren, Jingnan Wang, Hongwu Zhang, David Y.B. Deng, Lei Zhang, Changzhen Shang, Yajin Chen

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma

    TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma 由 Wenliang Tan, Xuan Luo, Wenda Li, Jinyi Zhong, Jun Cao, Sicong Zhu, Xianqing Chen, Rui Zhou, Changzhen Shang, Yajin Chen

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro

    Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro 由 Lihong Lv, Yun-Le Wan, Yan Lin, Wei Zhang, Mei Yang, Guolin Li, Haoming Lin, Changzhen Shang, Yajin Chen, Min Jun

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy

    Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional th... 由 Yonglin Hua, Zhixian Sun, Yuxin Xiao, Huilong Li, Xiaowu Ma, Xuan Luo, Wenliang Tan, Zhiqin Xie, Ziyu Zhang, Chenwei Tang, Hongkai Zhuang, Weikai Xu, Haihong Zhu, Yajin Chen, Changzhen Shang

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA

    CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA 由 Chenwei Tang, Hongkai Zhuang, Wentao Wang, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Ziyu Zhang, Jiahao Jiang, Zhiqin Xie, Wenliang Tan, Lei Yang, Songyao Liu, Yonglin Hua, Yuxin Xiao, Baoshan Ding, Yajin Chen, Changzhen Shang

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer

    SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer 由 Jin Li, Yuxian Bai, Zhendong Chen, Jieer Ying, Yabing Guo, Weijia Fang, Feng Zhang, Jianping Xiong, Tao Zhang, Zhiqiang Meng, Jingdong Zhang, Zhenggang Ren, Chunyi Hao, Yajin Chen, Xiaoyan Lin, Hongming Pan, Fuxiang Zhou, Xin Li, Fan Yu, Juan Zhang, Zhang Zhang, Shukui Qin

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial

    Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial 由 Zhenggang Ren, Michel Ducreux, Ghassan K. Abou‐Alfa, Philippe Merle, Weijia Fang, Julien Edeline, Zhiwei Li, Lihua Wu, Eric Assénat, Sheng Hu, Lorenza Rimassa, Tao� Zhang, Jean‐Frédéric Blanc, Hongming Pan, Paul J. Ross, Chia‐Jui Yen, Albert Tran, Guoliang Shao, Mohamed Bouattour, Yajin Chen, Tim Meyer, Jinlin Hou, David Tougeron, Yuxian Bai, Ming‐Mo Hou, Zhiqiang Meng, John Wu, Vincent Li, Sandra Chica-Duque, Ann‐Lii Cheng

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

    Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) 由 Hui‐Chuan Sun, Jian Zhou, Zheng Wang, Xiufeng Liu, Qing Xie, Weidong Jia, Ming Zhao, Xinyu Bi, Li Gong, Xueli Bai, Yuan Ji, Li Xu, Xiao‐Dong Zhu, Dousheng Bai, Yajin Chen, Yongjun Chen, Chaoliu Dai, Rong Guo, Wenzhi Guo, Chunyi Hao, Tao Huang, Zhiyong Huang, Deyu Li, Gang Li, Tao Li, Xiangcheng Li, Guangming Li, Liang Xiao, Jingfeng Liu, Fubao Liu, Shichun Lu, Zheng Lu, Wei‐Fu Lv, Yilei Mao, Guoliang Shao, Ying‐Hong Shi, Tianqiang Song, Guang Tan, Yunqiang Tang, Kaishan Tao, Chidan Wan, Guangyi Wang, Lu Wang, Shunxiang Wang, Tianfu Wen, Baocai Xing, Bang‐De Xiang, Sheng Yan, Dinghua Yang, Guowen Yin, Tao Yin, Zhenyu Yin, Zhengping Yu, Bixiang Zhang, Jialin Zhang, Shuijun Zhang, Ti Zhang, Yamin Zhang, Yubao Zhang, Aibin Zhang, Haitao Zhao, Ledu Zhou, Wu Zhang, Zhenyu Zhu, Shukui Qin, Feng Shen, Xiujun Cai, Gao‐Jun Teng, Jianqiang Cai, Minshan Chen, Qiang Li, Lianxin Liu, Weilin Wang, Tingbo Liang, Jiahong Dong, Xiaoping Chen, Xuehao Wang, Shusen Zheng, Jia Fan

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:

检索工具: